75 results
F-1
EX-10.4
GMAB
Genmab
28 May 19
Registration statement (foreign)
4:27pm
in the meeting. Each Party may permit non-voting observers to attend meetings of the JSC as the JSC determines. [***] shall be responsible … as expressly set forth herein, as between SGI and Genmab, Genmab shall be solely responsible for funding all costs of the research, development
DRS/A
EX-10.4
GMAB
Genmab
2 Apr 19
Draft registration statement (amended)
12:00am
in the meeting. Each Party may permit non-voting observers to attend meetings of the JSC as the JSC determines. [***] shall be responsible … as expressly set forth herein, as between SGI and Genmab, Genmab shall be solely responsible for funding all costs of the research, development
DRS/A
EX-10.5
GMAB
Genmab
2 Apr 19
Draft registration statement (amended)
12:00am
) report collaboration issues and progress to their management. Each Party will be solely responsible for any and all cost and expenses related … upon written notice to the other Party.
4.2 Responsibilities of Development Team. The DT shall be responsible for:
(A) implementing the Development
F-1
EX-10.5
GMAB
Genmab
28 May 19
Registration statement (foreign)
4:27pm
issues and progress to their management. Each Party will be solely responsible for any and all cost and expenses related to the appointment … to the other Party.
4.2 Responsibilities of Development Team. The DT shall be responsible for:
(A) implementing the Development Plan within the Budget
F-1
EX-10.6
s5l c4605n0
28 May 19
Registration statement (foreign)
4:27pm
F-1
EX-10.1
7tall
28 May 19
Registration statement (foreign)
4:27pm
6-K
EX-99.1
tve9i10m
19 Feb 20
Innovating antibodies, improving lives Annual Report 2019 Genmab A/S CVR No. 21 02 38 84
1:28pm
DRS/A
EX-10.1
bcujzmrk jtbpm
2 Apr 19
Draft registration statement (amended)
12:00am
20-F
EX-12.2
jkm ax0ek
30 Mar 20
Annual report (foreign)
5:12pm
DRS/A
EX-10.6
rak5kpdkirg7n l4
2 Apr 19
Draft registration statement (amended)
12:00am
20-F
EX-12.1
g03676
30 Mar 20
Annual report (foreign)
5:12pm
6-K
EX-99.1
awmfwu3 z87
23 Feb 21
Genmab 2020 Annual Report
12:38pm
6-K
EX-99.1
f4b00wan3bd dp
16 Feb 22
Genmab 2021 Annual Report
11:29am
6-K
EX-99.1
oacd0cz4
16 Feb 22
Genmab 2021 Annual Report
11:29am